IL91773A - History of 2-hemomethylidene, 2-ethnylidene and 2-ethenyl adenosine, process for making some of them, and pharmaceutical preparations - Google Patents

History of 2-hemomethylidene, 2-ethnylidene and 2-ethenyl adenosine, process for making some of them, and pharmaceutical preparations

Info

Publication number
IL91773A
IL91773A IL9177389A IL9177389A IL91773A IL 91773 A IL91773 A IL 91773A IL 9177389 A IL9177389 A IL 9177389A IL 9177389 A IL9177389 A IL 9177389A IL 91773 A IL91773 A IL 91773A
Authority
IL
Israel
Prior art keywords
compound
group
hydrogen
deoxy
adenosine
Prior art date
Application number
IL9177389A
Other languages
English (en)
Hebrew (he)
Other versions
IL91773A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL91773A0 publication Critical patent/IL91773A0/xx
Publication of IL91773A publication Critical patent/IL91773A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL9177389A 1988-09-27 1989-09-25 History of 2-hemomethylidene, 2-ethnylidene and 2-ethenyl adenosine, process for making some of them, and pharmaceutical preparations IL91773A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24991188A 1988-09-27 1988-09-27
US38939189A 1989-08-03 1989-08-03

Publications (2)

Publication Number Publication Date
IL91773A0 IL91773A0 (en) 1990-06-10
IL91773A true IL91773A (en) 1994-02-27

Family

ID=26940460

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9177389A IL91773A (en) 1988-09-27 1989-09-25 History of 2-hemomethylidene, 2-ethnylidene and 2-ethenyl adenosine, process for making some of them, and pharmaceutical preparations

Country Status (18)

Country Link
EP (1) EP0365849B1 (ja)
JP (1) JP2968002B2 (ja)
KR (1) KR0146333B1 (ja)
CN (1) CN1046334A (ja)
AR (1) AR248283A1 (ja)
AT (1) ATE111477T1 (ja)
AU (1) AU621664B2 (ja)
CA (1) CA1336903C (ja)
DE (1) DE68918215T2 (ja)
DK (1) DK171237B1 (ja)
ES (1) ES2063796T3 (ja)
FI (1) FI94763C (ja)
HU (1) HU204843B (ja)
IE (1) IE63561B1 (ja)
IL (1) IL91773A (ja)
NO (1) NO171857C (ja)
NZ (1) NZ230766A (ja)
PT (1) PT91803B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340816A (en) * 1990-10-18 1994-08-23 E. R. Squibb & Sons, Inc. Hydroxymethyl(methylenecyclopentyl) purines and pyrimidines
US5206244A (en) * 1990-10-18 1993-04-27 E. R. Squibb & Sons, Inc. Hydroxymethyl (methylenecyclopentyl) purines and pyrimidines
FR2668153B1 (fr) * 1990-10-22 1995-03-31 Pasteur Merieux Serums Vacc Nouveaux composes ribonucleosides, leur procede de preparation et les medicaments les contenant.
US5589587A (en) * 1992-05-12 1996-12-31 Merrell Pharmaceuticals Inc. Process for the preparation of ribonucleotide reductase inhibitors
AU662630B2 (en) * 1992-05-12 1995-09-07 Aventis Inc. A process for the preparation of ribonucleotide reductase inhibitors
US5627053A (en) * 1994-03-29 1997-05-06 Ribozyme Pharmaceuticals, Inc. 2'deoxy-2'-alkylnucleotide containing nucleic acid
US5811408A (en) * 1994-07-12 1998-09-22 Yamasa Corporation 2'-deoxy-2'-(substituted or unsubstituted)methylidene-4'-thionucleosides
AU784794B2 (en) * 1999-06-09 2006-06-22 Anticancer, Inc. Modulators of methylation for control of bacterial virulence
US6579857B1 (en) 1999-06-11 2003-06-17 Evanston Northwestern Healthcare Research Institute Combination cancer therapy comprising adenosine and deaminase enzyme inhibitors
US20040002476A1 (en) * 2002-02-14 2004-01-01 Stuyver Lieven J. Modified fluorinated nucleoside analogues
UA117095C2 (uk) 2011-12-22 2018-06-25 Аліос Біофарма, Інк. Нуклеозидна сполука або її фармацевтично прийнятна сіль
USRE48171E1 (en) 2012-03-21 2020-08-25 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof
US9441007B2 (en) 2012-03-21 2016-09-13 Alios Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL84414A0 (en) * 1986-11-14 1988-04-29 Ciba Geigy Ag N9-cyclopentyl-substituted adenine derivatives
US5047520A (en) * 1987-03-19 1991-09-10 Yamasa Shoyu Kabushiki Kaisha 2'-alkylidenepyrimidine nucleoside derivatives, process for production thereof, and uses thereof
NZ225906A (en) * 1987-08-26 1990-10-26 Merrell Dow Pharma Aristeromycin/adenosine derivatives and pharmaceutical compositions
ZA894534B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Novel neplanocin derivatives

Also Published As

Publication number Publication date
DK171237B1 (da) 1996-08-05
PT91803B (pt) 1995-05-31
CA1336903C (en) 1995-09-05
IE63561B1 (en) 1995-05-17
NO171857B (no) 1993-02-01
AU621664B2 (en) 1992-03-19
DK473289D0 (da) 1989-09-26
AU4176089A (en) 1990-04-05
IE893080L (en) 1990-03-27
JP2968002B2 (ja) 1999-10-25
ATE111477T1 (de) 1994-09-15
EP0365849A3 (en) 1990-12-27
NO893826D0 (no) 1989-09-26
AR248283A1 (es) 1995-07-12
JPH02160769A (ja) 1990-06-20
CN1046334A (zh) 1990-10-24
IL91773A0 (en) 1990-06-10
EP0365849B1 (en) 1994-09-14
ES2063796T3 (es) 1995-01-16
KR0146333B1 (ko) 1998-08-01
HUT50844A (en) 1990-03-28
HU204843B (en) 1992-02-28
KR900004736A (ko) 1990-04-12
NO893826L (no) 1990-03-28
EP0365849A2 (en) 1990-05-02
FI894546A (fi) 1990-03-28
FI94763C (fi) 1995-10-25
FI94763B (fi) 1995-07-14
NO171857C (no) 1993-05-12
PT91803A (pt) 1990-03-30
DK473289A (da) 1990-03-28
DE68918215T2 (de) 1995-02-02
NZ230766A (en) 1992-07-28
FI894546A0 (fi) 1989-09-26
DE68918215D1 (de) 1994-10-20

Similar Documents

Publication Publication Date Title
CA2002648C (en) 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives
US5792841A (en) 2'-halomethylidene, 2'-ethenylidene and 2'-ethynl cytidine, uridine and guanosine derivatives
EP0365849B1 (en) Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives
AU606792B2 (en) Novel acetylenic, cyano and allenic aristeromycin/adenosine derivatives
US5378693A (en) 2'-halomethylidene cytidine, uridine and guanosine compounds and their pharmaceutical compositions
IE81117B1 (en) Novel aristeromycin/adenosine derivatives
US5607925A (en) Treatment of carcinoma by administration of 2'-halomethylidenyl-2'-deoxynucleosides
US4997925A (en) 5'-deoxy-5',5'-dihalo adenosines and purine analogues

Legal Events

Date Code Title Description
RH1 Patent not in force
HC Change of name of proprietor(s)

Owner name: AVENTIS INC.

Free format text: FORMER NAME:MERRELL PHARMACEUTICALS INC.